This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Brunsvigia bosmaniae
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
South African amaryllid bulb plant used by Khoi and San peoples for sores, wounds, and rheumatic conditions.
South African amaryllid bulb plant used by Khoi and San peoples for sores, wounds, and rheumatic conditions. Key active compounds include lycorine, haemanthamine, tannins.
lycorine, along with haemanthamine and tannins, are the primary bioactive compounds in Brunsvigia bosmaniae. These compounds modulates NF-κB and COX-2 inflammatory pathways, acts on pain pathways via anti-inflammatory and neuroactive effects, promotes tissue regeneration and modulates local inflammation.
Analgesic effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Wound healing
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory
Wound treatment by Khoi and San
Based on traditional use; clinical evidence limited
Sores and skin conditions
Based on traditional use; clinical evidence limited
Rheumatic conditions
Based on traditional use; clinical evidence limited
Found an error or have a correction for Brunsvigia bosmaniae?
Report an Issue →